Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 250 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $23.031 million which missed the analyst consensus estimate of $24.875 million by 7.41 percent. This is a 24.33 percent decrease over sales of $30.436 million the same period last year.